At a glance
ClinicalIndex Comparison RecordN/ACompleted· 13 enrolled
Drug / intervention
InMode Morpheus8 Systemdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Clinical Assessment of Skin Quality and Efficacy of Dermal Line Improvement Following Four Bipolar Radiofrequency Microneedling Treatments
University of Texas Southwestern Medical Center·interventional·Posted Oct 20, 2021·Updated Oct 31, 2023
In Brief
A clinical study evaluating InMode Morpheus8 System for Aging. Completed, enrolled 13 participants across 1 site.
Detailed Summary
This study intends to evaluate the safety and effectiveness of the InMode Morpheus8 System to treat facial and neck skin and assess its effect on skin quality and dermal lines. This device has been FDA cleared for full body subdermal adipose tissue remodeling.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAging
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
20222023202420252026
First PostedOct 2021
Enrollment StartJan 2022
Primary CompletionDec 2022
TodayJul 2026
First PostedOct 20, 2021
Enrollment StartJan 14, 2022
Primary CompletionDec 22, 2022
TodayJul 2, 2026
Enrollment to primary: 11 monthsPosted 4.7 years ago
Interventions
InMode Morpheus8 Systemdevice
The InMode Morpheus8 System is a bipolar fractional radiofrequency device which uses microneedles and thermal heat to stimulate neocollagenesis and neoelastogenesis.